Breaking Gene Therapy News
-
Cell and Gene Therapy Manufacturing Services Market Is Expected To Grow At an Astonishing CAGR of Over 12.4% By 2030 - Digital Journal
Dec 5, 2022 | 06:42 amCell and Gene Therapy Manufacturing Services Market Is Expected To Grow At an Astonishing CAGR of Over 12.4% By 2030 Digital Journal
Read more... -
CTAD 2022 – Lexeo takes baby steps towards an Alzheimer’s gene therapy - Evaluate Pharma
Dec 3, 2022 | 13:00 pmCTAD 2022 – Lexeo takes baby steps towards an Alzheimer’s gene therapy Evaluate Pharma
Read more... -
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial - The New York Times
Dec 2, 2022 | 22:55 pmAlzheimer’s APOE4 Genetic Risk Targeted in Promising Trial The New York Times
Read more... -
Despite Eye-Popping $3.5 Million Price Tag For Gene Therapy Hemgenix, Budget Impact For Most Payers Will Be Relatively Small - Forbes
Dec 2, 2022 | 17:11 pmDespite Eye-Popping $3.5 Million Price Tag For Gene Therapy Hemgenix, Budget Impact For Most Payers Will Be Relatively Small ForbesFDA approves first haemophilia B gene therapy Nature.comFDA Approves $3.5 Million Hemophilia B Gene Therapy BioPharm InternationalFDA Approves First Gene Therapy for Hemophilia B Consultant360A $3.5M 'bargain'? CSL's hemophilia B drug sets new pricing benchmark, as gene therapy costs mount MM+M OnlineView Full Coverage on Google News
Read more... -
Gene Therapy Startup Partnered with Jim Wilson's U Penn Program Nets $65M - Inside Precision Medicine
Dec 2, 2022 | 16:32 pmGene Therapy Startup Partnered with Jim Wilson's U Penn Program Nets $65M Inside Precision MedicineGene therapy from Penn's Jim Wilson gets $65 million to treat liver disease 23 years after Gelsinger The Philadelphia InquirerStartup co-founded by Penn Gene Therapy Program's Jim Wilson receives $65 million in funding The Daily PennsylvanianScientists Receive $4.8M to Pursue Gene Therapy for 'Incurable' Disease today.ucsd.eduGene editing startup iECURE returns to investors for fresh funding BioPharma DiveView Full Coverage on Google News
Read more... -
RegenxBio, Abbvie work to sell first gene therapy products by 2025 - Washington Business Journal - The Business Journals
Nov 30, 2022 | 20:36 pmRegenxBio, Abbvie work to sell first gene therapy products by 2025 - Washington Business Journal The Business Journals
Read more... -
Global Gene Therapy Market Report 2022: Research & Development in Orphan Diseases and Advancements in Gene Therapy Presents Opportunities - ResearchAndMarkets.com - Business Wire
Nov 30, 2022 | 18:05 pmGlobal Gene Therapy Market Report 2022: Research & Development in Orphan Diseases and Advancements in Gene Therapy Presents Opportunities - ResearchAndMarkets.com Business Wire
Read more... -
FDA Review of Roctavian, Gene Therapy for Hem A, Moving Ahead | US... - Hemophilia News Today
Nov 30, 2022 | 16:36 pmFDA Review of Roctavian, Gene Therapy for Hem A, Moving Ahead | US... Hemophilia News Today
Read more... -
New Gene Editing Tool May Lead to 'Blanket' CF Gene Therapy | PASTE Aims to Address Diseases With Various Mutations - Cystic Fibrosis News Today
Nov 29, 2022 | 15:05 pmNew Gene Editing Tool May Lead to 'Blanket' CF Gene Therapy | PASTE Aims to Address Diseases With Various Mutations Cystic Fibrosis News Today
Read more... -
Bristol Myers has change of heart on cardiovascular gene therapy pact, terminating uniQure deal - FierceBiotech
Nov 29, 2022 | 14:15 pmBristol Myers has change of heart on cardiovascular gene therapy pact, terminating uniQure deal FierceBiotech
Read more... -
FDA grants speedy review to Sarepta's Duchenne gene therapy - BioPharma Dive
Nov 28, 2022 | 17:53 pmFDA grants speedy review to Sarepta's Duchenne gene therapy BioPharma Dive
Read more... -
Potential Modifier Gene Therapy for Degenerative Retinal Diseases - FierceBiotech
Nov 28, 2022 | 14:00 pmPotential Modifier Gene Therapy for Degenerative Retinal Diseases FierceBiotech
Read more... -
Mainstreaming cell and gene therapy – Realizing its potential - BioPharma Dive
Nov 28, 2022 | 11:11 amMainstreaming cell and gene therapy – Realizing its potential BioPharma Dive
Read more... -
Current Research and Logistical Considerations for Gene Therapy in Hemophilia - AJMC.com Managed Markets Network
Nov 25, 2022 | 17:26 pmCurrent Research and Logistical Considerations for Gene Therapy in Hemophilia AJMC.com Managed Markets Network
Read more... -
Measuring Potency of Cell and Gene Therapy Products - Technology Networks
Nov 25, 2022 | 01:00 amMeasuring Potency of Cell and Gene Therapy Products Technology Networks
Read more... -
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B - FDA.gov
Nov 22, 2022 | 09:00 amFDA Approves First Gene Therapy to Treat Adults with Hemophilia B FDA.gov
Read more... -
FDA approves a gene therapy for hemophilia B - STAT
Nov 22, 2022 | 09:00 amFDA approves a gene therapy for hemophilia B STAT
Read more... -
Gene Therapy Briefs: Cure Rare Disease CEO's Brother Died in Clinical Trial - Genetic Engineering & Biotechnology News
Nov 21, 2022 | 09:00 amGene Therapy Briefs: Cure Rare Disease CEO's Brother Died in Clinical Trial Genetic Engineering & Biotechnology News
Read more... -
Gene Therapy Myth Busting - Pfizer
Nov 18, 2022 | 22:41 pmGene Therapy Myth Busting Pfizer
Read more... -
Gene Therapy for Hemophilia Is on the Brink of FDA Approval - Managed Healthcare Executive
Nov 17, 2022 | 09:00 amGene Therapy for Hemophilia Is on the Brink of FDA Approval Managed Healthcare Executive
Read more...